Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1970 Jun;6(6):829–839.

Genesis of antinuclear antibody in NZB/W mice: role of genetic factors and of viral infections

P H Lambert, F J Dixon
PMCID: PMC1712825  PMID: 4320133

Abstract

Antinuclear antibodies could be induced in young NZB/W mice long before the natural occurrence of such antibodies by immunization with heat denatured DNA coupled to methylated bovine serum albumin (DNA m BSA). While induction of antinuclear antibodies was possible in several strains of mice (NZB/W, A/J, DBA/2, CBA and AKR), NZB/W mice had by far the highest titre of antibody. A genetic determination of this immune hyperreactivity to DNA was suggested by study of the parental strains. The NZW mice which have a low incidence of spontaneously occurring antinuclear antibody made as much antinuclear antibody upon immunization with DNA m BSA as did the NZB/W mice, while NZB mice which develop naturally a moderate incidence of antinuclear antibody responded relatively poorly to immunization.

It seemed possible that while the native hyperreactivity of NZB/W mice to DNA might be inherited from the NZW parent, the antigenic stimulus calling forth the anti-DNA response might be transmitted from the NZB parent. A possible source of this stimulus might be a viral infection such as that caused by the leukemia virus found in NZB mice which might liberate unusual amounts or kinds of host nuclear antigens or provide viral nucleic acid antigens. In support of this, induced neonatal infection of NZB/W mice with Polyoma virus markedly enhanced their antinuclear antibody response. Also, neonatal thymectomy of NZW mice which predisposes to reduced resistance to infection also enhanced antinuclear antibody formation. And finally, Statolon treatment designed to increase and maintain interferon levels in both normal and thymectomized NZW mice reduced antinuclear antibody formation.

Full text

PDF
829

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BURNET F. M. The immunological significance of the thymus: an extension of the clonal selection theory of immunity. Australas Ann Med. 1962 May;11:79–91. doi: 10.1111/imj.1962.11.2.79. [DOI] [PubMed] [Google Scholar]
  2. Brézin C., Cannat A., Sekiguchi M. Présence d'anticorps sériques antinucléaires chez des souris thymectomisées a la naissance. Rev Fr Etud Clin Biol. 1965 Oct;10(8):839–841. [PubMed] [Google Scholar]
  3. Burnet M., Holmes M. C. Genetic investigations of autoimmune disease in mice. Nature. 1965 Jul 24;207(995):368–371. doi: 10.1038/207368a0. [DOI] [PubMed] [Google Scholar]
  4. CLARK H. F., SHEPARD C. C. A DIALYSIS TECHNIQUE FOR PREPARING FLUORESCENT ANTIBODY. Virology. 1963 Aug;20:642–644. doi: 10.1016/0042-6822(63)90292-7. [DOI] [PubMed] [Google Scholar]
  5. Carter M. J., Parsons D. S. Carbonic anhydrase activity of mucosa of small intestine and colon. Nature. 1968 Jul 13;219(5150):176–177. doi: 10.1038/219176a0. [DOI] [PubMed] [Google Scholar]
  6. Cerottini J. C., Lambert P. H., Dixon F. J. Comparison of the immune responsiveness of NZB and NZB X NZW F1 hybrid mice with that of other strains of mice. J Exp Med. 1969 Nov 1;130(5):1093–1105. doi: 10.1084/jem.130.5.1093. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chang S. S., Hildemann W. H., Rasmussen A. F., Jr Immunogenetic aspects of polyoma virus susceptibility in mice. J Natl Cancer Inst. 1968 Feb;40(2):363–375. [PubMed] [Google Scholar]
  8. East J., Branca M. Autoimmune reactions and malignant changes in germ-free New Zealand Black mice. Clin Exp Immunol. 1969 Jun;4(6):621–635. [PMC free article] [PubMed] [Google Scholar]
  9. Evans M. M., Williamson W. G., Irvine W. J. The appearance of immunological competence at an early age in New Zealand black mice. Clin Exp Immunol. 1968 Jun;3(5):375–383. [PMC free article] [PubMed] [Google Scholar]
  10. FARR R. S. A quantitative immunochemical measure of the primary interaction between I BSA and antibody. J Infect Dis. 1958 Nov-Dec;103(3):239–262. doi: 10.1093/infdis/103.3.239. [DOI] [PubMed] [Google Scholar]
  11. Friou G. J., Teague P. O. Spontaneous Autoimmunity in Mice: Antibodies to Nucleoprotein in Strain A/J. Science. 1964 Mar 20;143(3612):1333–1334. doi: 10.1126/science.143.3612.1333. [DOI] [PubMed] [Google Scholar]
  12. HOLMES M. C., BURNET F. M. THE INHERITANCE OF AUTOIMMUNE DISEASE IN MICE: A STUDY OF HYBRIDS OF THE STRAINS NZB AND C3H. Heredity (Edinb) 1964 Aug;19:419–434. doi: 10.1038/hdy.1964.52. [DOI] [PubMed] [Google Scholar]
  13. HOLMES M. C., GORIE J., BURNET F. M. Transmission by splenic cells of an autoimmune disease occurring spontaneously in mice. Lancet. 1961 Sep 16;2(7203):638–639. doi: 10.1016/s0140-6736(61)90313-0. [DOI] [PubMed] [Google Scholar]
  14. Howie J. B., Helyer B. J. The immunology and pathology of NZB mice. Adv Immunol. 1968;9:215–266. doi: 10.1016/s0065-2776(08)60444-7. [DOI] [PubMed] [Google Scholar]
  15. Kleinschmidt W. J., Murphy E. B. Interferon induction with statolon in the intact animal. Bacteriol Rev. 1967 Jun;31(2):132–137. doi: 10.1128/br.31.2.132-137.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kleischmidt W. J., Ellis L. F., Van Frank R. M., Murphy E. B. Interferon stimulation by a double stranded RNA of a mycophage in statolon preparations. Nature. 1968 Oct 12;220(5163):167–168. doi: 10.1038/220167a0. [DOI] [PubMed] [Google Scholar]
  17. Lambert P. H., Dixon F. J. Pathogenesis of the glomerulonephritis of NZB/W mice. J Exp Med. 1968 Mar 1;127(3):507–522. doi: 10.1084/jem.127.3.507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Mellors R. C., Aoki T., Huebner R. J. Further implication of murine leukemia-like virs in the disorders of NZB mice. J Exp Med. 1969 May 1;129(5):1045–1062. doi: 10.1084/jem.129.5.1045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Mellors R. C., Huang C. Y. Immunopathology of NZB/BL mice. V. Viruslike (filtrable) agent separable from lymphoma cells and identifiable by electron microscopy. J Exp Med. 1966 Dec 1;124(6):1031–1038. doi: 10.1084/jem.124.6.1031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Mellors R. C., Huang C. Y. Immunopathology of NZB/BL mice. VI. Virus separable from spleen and pathogenic for Swiss mice. J Exp Med. 1967 Jul 1;126(1):53–62. doi: 10.1084/jem.126.1.53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Morton J. I., Siegel B. V. Response of NZB mice to foreign antigen and development of autoimmune disease. J Reticuloendothel Soc. 1969 Feb;6(1):78–93. [PubMed] [Google Scholar]
  22. NORINS L. C., HOLMES M. C. ANTINUCLEAR FACTOR IN MICE. J Immunol. 1964 Jul;93:148–154. [PubMed] [Google Scholar]
  23. PLESCIA O. J., BRAUN W., PALCZUK N. C. PRODUCTION OF ANTIBODIES TO DENATURED DEOXYRIBONUCLEIC ACID (DNA). Proc Natl Acad Sci U S A. 1964 Aug;52:279–285. doi: 10.1073/pnas.52.2.279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Playfair J. H. Strain differences in the immune response of mice. I. The neonatal response to sheep red cells. Immunology. 1968 Jul;15(1):35–50. [PMC free article] [PubMed] [Google Scholar]
  25. Salomon J. C., Benveniste J. The immune response in NZBxNZW F1 hybrid mice. Clin Exp Immunol. 1969 Feb;4(2):213–225. [PMC free article] [PubMed] [Google Scholar]
  26. Staples P. J., Talal N. Relative inability to induce tolerance in adult NZB and NZB-NZW F1 mice. J Exp Med. 1969 Jan 1;129(1):123–139. doi: 10.1084/jem.129.1.123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Steinberg A. D., Baron S., Talal N. The pathogenesis of autoimmunity in New Zealand mice, I. Induction of antinucleic acid antibodies by polyinosinic-polycytidylic acid. Proc Natl Acad Sci U S A. 1969 Aug;63(4):1102–1107. doi: 10.1073/pnas.63.4.1102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Stutman O., Yunis E. J., Good R. A. Deficient immunologic functions of NZB mice. Proc Soc Exp Biol Med. 1968 Apr;127(4):1204–1207. doi: 10.3181/00379727-127-32910. [DOI] [PubMed] [Google Scholar]
  29. Teague P. O., Friou G. J., Myers L. L. Anti-nuclear antibodies in mice. I. Influence of age and possible genetic factors on spontaneous and induced responses. J Immunol. 1968 Oct;101(4):791–798. [PubMed] [Google Scholar]
  30. Thivolet J., Monier J. C., Ruel J. P., Richard M. H. Antinuclear autoantibodies in Swiss mice thymectomized at birth. Nature. 1967 Jun 10;214(5093):1134–1136. doi: 10.1038/2141134a0. [DOI] [PubMed] [Google Scholar]
  31. WEIGLE W. O. IMMUNOCHEMICAL PROPERTIES OF HEMOCYANIN. Immunochemistry. 1964 Dec;1:295–302. doi: 10.1016/0019-2791(64)90030-8. [DOI] [PubMed] [Google Scholar]
  32. de Vries M. J., Hijmans W. Pathological changes of thymic epithelial cells and autoimmune disease in NZB, NZW and (NZB x NZW)F1 mice. Immunology. 1967 Feb;12(2):179–196. [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES